201 related articles for article (PubMed ID: 15366674)
21. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Graham DY
Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
[TBL] [Abstract][Full Text] [Related]
22. [
Joo MK
Korean J Gastroenterol; 2020 Nov; 76(5):227-231. PubMed ID: 33234768
[TBL] [Abstract][Full Text] [Related]
23. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; KwiecieĊ S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
24. Interaction between Helicobacter pylori infection, nonsteroidal anti-inflammatory drugs and/or low-dose aspirin use: old question new insights.
Sostres C; Gargallo CJ; Lanas A
World J Gastroenterol; 2014 Jul; 20(28):9439-50. PubMed ID: 25071338
[TBL] [Abstract][Full Text] [Related]
25. Should we eradicate Helicobacter pylori infection in patients receiving nonsteroidal anti-inflammatory drugs or low-dose aspirin?
Chan FK
Chin J Dig Dis; 2005; 6(1):1-5. PubMed ID: 15667550
[TBL] [Abstract][Full Text] [Related]
26. Peptic ulcer disease today.
Yuan Y; Padol IT; Hunt RH
Nat Clin Pract Gastroenterol Hepatol; 2006 Feb; 3(2):80-9. PubMed ID: 16456574
[TBL] [Abstract][Full Text] [Related]
27. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
28. Ulcer risk factors: interactions between Helicobacter pylori infection, nonsteroidal use, and age.
Schubert TT; Bologna SD; Nensey Y; Schubert AB; Mascha EJ; Ma CK
Am J Med; 1993 Apr; 94(4):413-8. PubMed ID: 8475935
[TBL] [Abstract][Full Text] [Related]
29. Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use.
al-Assi MT; Genta RM; Karttunen TJ; Graham DY
Endoscopy; 1996 Feb; 28(2):229-33. PubMed ID: 8739738
[TBL] [Abstract][Full Text] [Related]
30. The relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010.
Musumba C; Jorgensen A; Sutton L; Van Eker D; Moorcroft J; Hopkins M; Pritchard DM; Pirmohamed M
Aliment Pharmacol Ther; 2012 Jul; 36(1):48-56. PubMed ID: 22554233
[TBL] [Abstract][Full Text] [Related]
31. How does Helicobacter pylori infection interact with non-steroidal anti-inflammatory drugs?
Chan FK; Sung JJ
Baillieres Best Pract Res Clin Gastroenterol; 2000 Feb; 14(1):161-72. PubMed ID: 10749096
[TBL] [Abstract][Full Text] [Related]
32. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis.
Tang CL; Ye F; Liu W; Pan XL; Qian J; Zhang GX
Helicobacter; 2012 Aug; 17(4):286-96. PubMed ID: 22759329
[TBL] [Abstract][Full Text] [Related]
33. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
Hawkey CJ
Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S17-20. PubMed ID: 10929894
[TBL] [Abstract][Full Text] [Related]
34. Frequency of NSAID induced peptic ulcer disease.
Hamid S; Yakoob J; Jafri W; Islam S; Abid S; Islam M
J Pak Med Assoc; 2006 May; 56(5):218-22. PubMed ID: 16767948
[TBL] [Abstract][Full Text] [Related]
35. Evidence-based clinical practice guidelines for peptic ulcer disease 2015.
Satoh K; Yoshino J; Akamatsu T; Itoh T; Kato M; Kamada T; Takagi A; Chiba T; Nomura S; Mizokami Y; Murakami K; Sakamoto C; Hiraishi H; Ichinose M; Uemura N; Goto H; Joh T; Miwa H; Sugano K; Shimosegawa T
J Gastroenterol; 2016 Mar; 51(3):177-94. PubMed ID: 26879862
[TBL] [Abstract][Full Text] [Related]
36. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
37. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.
Chan FK; To KF; Wu JC; Yung MY; Leung WK; Kwok T; Hui Y; Chan HL; Chan CS; Hui E; Woo J; Sung JJ
Lancet; 2002 Jan; 359(9300):9-13. PubMed ID: 11809180
[TBL] [Abstract][Full Text] [Related]
38. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis.
Huang JQ; Sridhar S; Hunt RH
Lancet; 2002 Jan; 359(9300):14-22. PubMed ID: 11809181
[TBL] [Abstract][Full Text] [Related]
39. The relation between Helicobacter pylori and nonsteroidal anti-inflammatory drugs.
Barkin J
Am J Med; 1998 Nov; 105(5A):22S-27S. PubMed ID: 9855172
[TBL] [Abstract][Full Text] [Related]
40. Is Helicobacter pylori eradication useful in patients taking NSAIDs?
Hawkey CJ
Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S47-50; discussion S73. PubMed ID: 10503823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]